Ajooni Biotech

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE820Y01021
  • NSEID: AJOONI
  • BSEID:
INR
3.75
0.04 (1.08%)
BSENSE

Jun 23, 12:04 PM

BSE+NSE Vol: 114203

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Veerhealth Care
Phaarmasia
JFL Life
Vineet Laborator
Ajooni Biotech
Biofil Chemicals
Samrat Pharma
Vilin Bio Med
Onyx Biotec
Asston Pharmaceu
Bacil Pharma

Why is Ajooni Biotech Ltd ?

1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 4.56%
2
Below par performance in long term as well as near term
  • Along with generating -100.00% returns in the last 1 year, the stock has also underperformed BSE500 in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Ajooni Biotech for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Ajooni Biotech
-32.8%
-0.75
42.99%
Sensex
-6.39%
-0.44
13.24%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
28.60%
EBIT Growth (5y)
25.13%
EBIT to Interest (avg)
2.35
Debt to EBITDA (avg)
1.75
Net Debt to Equity (avg)
0.19
Sales to Capital Employed (avg)
1.56
Tax Ratio
24.91%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.42%
ROE (avg)
4.53%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
0.70
EV to EBIT
20.06
EV to EBITDA
12.98
EV to Capital Employed
0.75
EV to Sales
0.45
PEG Ratio
0.52
Dividend Yield
NA
ROCE (Latest)
3.73%
ROE (Latest)
4.73%
Loading Valuation Snapshot...
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

14What is working for the Company
NET SALES(Q)

Highest at Rs 60.62 cr

DEBTORS TURNOVER RATIO(HY)

Highest at 10.23 times

-5What is not working for the Company
OPERATING PROFIT TO NET SALES (Q)

Lowest at 1.65%

PBT LESS OI(Q)

Lowest at Rs -0.18 cr.

NON-OPERATING INCOME(Q)

is 116.07 % of Profit Before Tax (PBT

EPS(Q)

Lowest at Rs 0.06

Loading Valuation Snapshot...

Here's what is working for Ajooni Biotech

Net Sales - Quarterly
At Rs 60.62 cr has Grown at 107.11%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Net Sales - Quarterly
Highest at Rs 60.62 cr and Grown
each quarter in the last five quarters
MOJO Watch
Near term sales trend is very positive

Net Sales (Rs Cr)

Debtors Turnover Ratio- Half Yearly
Highest at 10.23 times
in the last five half yearly periods
MOJO Watch
Company has been able to settle its Debtors faster

Debtors Turnover Ratio

Here's what is not working for Ajooni Biotech

Operating Profit Margin - Quarterly
Lowest at 1.65%
in the last five quarters
MOJO Watch
Company's efficiency has deteriorated

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Lowest at Rs -0.18 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is negative

PBT less Other Income (Rs Cr)

Non Operating Income - Quarterly
is 116.07 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model

Non Operating Income to PBT

Earnings per Share (EPS) - Quarterly
Lowest at Rs 0.06
in the last five quarters
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (Rs)